Last reviewed · How we verify
290-800 nm sunscreen
290-800 nm sunscreen is a Small molecule drug developed by Universidad Autonoma de San Luis Potosí. It is currently FDA-approved. Also known as: Benzophenone-3, Octinoxate, Octocrylene, Titanium Dioxide.
Researchers have studied the effectiveness of 290-400 nm sunscreen and 290-800 nm sunscreen in treating melasma, a condition studied in clinical trials. The use of 290-800 nm sunscreen is being investigated as a potential treatment for melasma in a double-blind randomized study.
At a glance
| Generic name | 290-800 nm sunscreen |
|---|---|
| Also known as | Benzophenone-3, Octinoxate, Octocrylene, Titanium Dioxide, Zinc Oxide |
| Sponsor | Universidad Autonoma de San Luis Potosí |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 290-800 nm sunscreen CI brief — competitive landscape report
- 290-800 nm sunscreen updates RSS · CI watch RSS
- Universidad Autonoma de San Luis Potosí portfolio CI
Frequently asked questions about 290-800 nm sunscreen
What is 290-800 nm sunscreen?
Who makes 290-800 nm sunscreen?
Is 290-800 nm sunscreen also known as anything else?
What development phase is 290-800 nm sunscreen in?
Related
- Manufacturer: Universidad Autonoma de San Luis Potosí — full pipeline
- Also known as: Benzophenone-3, Octinoxate, Octocrylene, Titanium Dioxide, Zinc Oxide
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing